EGTX.ST
Egetis Therapeutics AB (publ)
Price:  
6.68 
SEK
Volume:  
1,440,486.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGTX.ST WACC - Weighted Average Cost of Capital

The WACC of Egetis Therapeutics AB (publ) (EGTX.ST) is 6.2%.

The Cost of Equity of Egetis Therapeutics AB (publ) (EGTX.ST) is 6.20%.
The Cost of Debt of Egetis Therapeutics AB (publ) (EGTX.ST) is 7.00%.

Range Selected
Cost of equity 5.00% - 7.40% 6.20%
Tax rate 20.60% - 20.90% 20.75%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.0% - 7.3% 6.2%
WACC

EGTX.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.39 0.55
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.00% 7.40%
Tax rate 20.60% 20.90%
Debt/Equity ratio 0.05 0.05
Cost of debt 7.00% 7.00%
After-tax WACC 5.0% 7.3%
Selected WACC 6.2%